Phase 4 PTSD Trial, Recruiting NCT07382596 Sponsor: Dr. Dean Reeves Clinic Condition: PTSD
Back to Ptsd

Phase 4 PTSD Trial, Recruiting

NCT07382596
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are not currently taking part in another PTSD treatment study
  • People who have reliable transport to get to appointments
  • People who are comfortable using computers
  • People who have tried 2 or more medications for PTSD symptoms
  • People who have tried 2 or more non-medication treatments for PTSD symptoms
  • People who do not have a known life-threatening illness
  • People who are not taking daily narcotic medications
  • People who do not drink 3 or more alcoholic drinks on an average day
  • People who do not have active plans to end their life
  • People who do not have major surgery planned
  • People who are not experiencing major life stress that could make it hard to complete the study
  • People who have had PTSD symptoms for more than 1 year
  • People who are not planning to move away within the next 18 months
  • People who live within one hour of Portland OR, Madison WI, or Lexington KY
  • People who are willing to provide 2 email addresses and 2 phone numbers as contact methods
  • People who are willing to answer questions on multiple occasions over the course of a year
  • People who are willing to be assigned to 3 months of standard care treatment
  • People who have not been diagnosed with schizophrenia, Borderline Personality Disorder, or Bipolar Disorder
  • People who do not have a severe fear of needles
  • People whose chronic pain is rated 5 out of 10 or lower
  • People who score 50 or higher on a standard PTSD symptom questionnaire called the PCL-C (confirm with trial site)

Who may not be able to join:

  • No specific exclusion criteria were listed separately in the official trial information (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Kenneth D Reeves, M.D., Dr. Dean Reeves Clinic

Phone: 9133621600

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Dr. Dean Reeves Clinic
Registry
ClinicalTrials.gov
Start date
16 May 2026
Est. completion
1 March 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Post traumatic checklist for civilians

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov